GlobeStar Therapeutics Corporation

GSTC · OTC
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$198-$175-$164-$351
Dep. & Amort.$15$7$5$24
Deferred Tax$0$0-$38$9
Stock-Based Comp.-$13$24$25$109
Change in WC$187$132$91$160
Other Non-Cash-$11$0$38-$24
Operating Cash Flow-$20-$12-$43-$73
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$25$0$25$40
Stock Issued-$926$18$18$32
Stock Repurch.$0$0$0$0
Dividends Paid$0$0-$32-$96
Other Fin. Act.-$5-$5$33$97
Financing Cash Flow$20$12$43$73
Forex Effect$0$0$0$0
Net Chg. in Cash$0$0$0$0
Supplemental Information
Beg. Cash$0$0$0$0
End Cash$0$0$0$0
Free Cash Flow-$20-$12-$43-$73